ADAR1 Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.09M | Buy |
302,125
+38,700
| +15% | +$524K | 0.63% | 37 |
|
|
2025
Q1 | $4.18M | Sell |
263,425
-578,116
| -69% | -$9.18M | 0.78% | 33 |
|
|
2024
Q4 | $10.4M | Buy |
841,541
+112,140
| +15% | +$1.38M | 2.07% | 11 |
|
|
2024
Q3 | $8.83M | Buy |
729,401
+704,035
| +2,776% | +$8.53M | 1.44% | 14 |
|
|
2024
Q2 | $297K | Buy |
25,366
+1,366
| +6% | +$16K | 0.06% | 118 |
|
|
2024
Q1 | $310K | Buy |
+24,000
| New | +$310K | 0.07% | 95 |
|